The sold production of ozone therapy, oxygen therapy, aerosol therapy, and respiration apparatus in the UK is forecasted to decrease steadily from 2024 through 2028. In 2024, the value is projected to be 39.758 million items, declining to 26.755 million items by 2028. This represents a consistent decline over the years with a compounded annual growth rate (CAGR) reflecting a decrease. The year-on-year percentage drop indicates a significant downward trend.
Future trends to watch for include technological advancements in respiratory apparatus and the impact of policy changes on healthcare expenditure. These could influence the market dynamics and potentially stabilize production levels beyond 2028.
